pyrazines has been researched along with FMR1-Related Primary Ovarian Insufficiency in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbott, DH; Kropp, J; Ringelstetter, AK; Roti Roti, EC; Salih, SM | 1 |
1 other study(ies) available for pyrazines and FMR1-Related Primary Ovarian Insufficiency
| Article | Year |
|---|---|
Bortezomib prevents acute doxorubicin ovarian insult and follicle demise, improving the fertility window and pup birth weight in mice.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Birth Weight; Boronic Acids; Bortezomib; DNA Damage; Doxorubicin; Female; Fertility; Humans; Litter Size; Mice; Ovarian Follicle; Ovarian Neoplasms; Ovary; Primary Ovarian Insufficiency; Pyrazines | 2014 |